<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02435940</url>
  </required_header>
  <id_info>
    <org_study_id>FFB-Registry-01</org_study_id>
    <nct_id>NCT02435940</nct_id>
  </id_info>
  <brief_title>Inherited Retinal Degenerative Disease Registry</brief_title>
  <acronym>MRTR</acronym>
  <official_title>Foundation Fighting Blindness My Retina Tracker Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foundation Fighting Blindness</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Foundation Fighting Blindness</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The My Retina TrackerÂ® Registry is sponsored by the Foundation Fighting Blindness and is for&#xD;
      people affected by one of the rare inherited retinal degenerative diseases studied by the&#xD;
      Foundation. It is a patient-initiated registry accessible via a secure on-line portal at&#xD;
      www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile&#xD;
      that captures their perspective on their retinal disease and its progress; family history;&#xD;
      genetic testing results; preventive measures; general health and interest in participation in&#xD;
      research studies. The participants may also choose to ask their clinician to add clinical&#xD;
      measurements and results at each clinical visit. Participants are urged to update the&#xD;
      information regularly to create longitudinal records of their disease, from their own&#xD;
      perspective, and their clinical progress. The overall goals of the Registry are: to better&#xD;
      understand the diversity within the inherited retinal degenerative diseases; to understand&#xD;
      the prevalence of the different diseases and gene variants; to assist in the establishment of&#xD;
      genotype-phenotype relationships; to help understand the natural history of the diseases; to&#xD;
      help accelerate research and development of clinical trials for treatments; and to provide a&#xD;
      tool to investigators that can assist with recruitment for research studies and clinical&#xD;
      trials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      My Retina Tracker Registry provides two portals for data entry and review. Initial&#xD;
      registration in the My Retina Tracker Registry is initiated by a participant, not a&#xD;
      clinician. Using the participant portal, the participant establishes a username and password,&#xD;
      is guided through on-line informed consent, and can then use an interactive guide to record&#xD;
      their ophthalmic and family history, genotype and other subjective diagnosis-related and&#xD;
      general health information. Drop-down menus and standardized vocabulary are used for database&#xD;
      consistency. They may also attach documents, such as medical records, to maintain their&#xD;
      personal medical files on their disease. Participants are encouraged to update their profiles&#xD;
      regularly to create a longitudinal history of their disease. Participants can see aggregated&#xD;
      data for all other participants in the registry and compare their own disease and status to&#xD;
      others.&#xD;
&#xD;
      After a profile has been established, Registry members may ask their clinician or genetic&#xD;
      counselor to add specific ophthalmic exam and measurement results to the profile. This is&#xD;
      done through the clinical portal which also uses a series of drop-down menus to expedite&#xD;
      entry and standardize data. Clinicians cannot see the participant data when adding the&#xD;
      clinical exam data. Participants are encouraged to collect this data at each medical exam, to&#xD;
      create a longitudinal clinical data set.&#xD;
&#xD;
      Access to de-identified data or study recruitment assistance is available to qualified&#xD;
      investigators who may inquire by contacting Coordinator@MyRetinaTracker.org. A process that&#xD;
      maintains patient anonymity and privacy protection, exists for researchers with Institutional&#xD;
      Review Board-approved projects who wish to contact registry participants of interest.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2037</completion_date>
  <primary_completion_date type="Anticipated">June 2037</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Number of Participants with Rare Diagnoses Within the Inherited Retinal Degenerative Disease Category as Defined by Clinical Evaluation</measure>
    <time_frame>Data collection is ongoing, up to 20 years.</time_frame>
    <description>Participant profiles broken out be disease category and genetic diagnosis</description>
  </primary_outcome>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Eye Diseases Hereditary</condition>
  <condition>Retinal Disease</condition>
  <condition>Achromatopsia</condition>
  <condition>Bardet-Biedl Syndrome</condition>
  <condition>Bassen-Kornzweig Syndrome</condition>
  <condition>Batten Disease</condition>
  <condition>Best Disease</condition>
  <condition>Choroidal Dystrophy</condition>
  <condition>Choroideremia</condition>
  <condition>Cone Dystrophy</condition>
  <condition>Cone-Rod Dystrophy</condition>
  <condition>Congenital Stationary Night Blindness</condition>
  <condition>Enhanced S-Cone Syndrome</condition>
  <condition>Fundus Albipunctatus</condition>
  <condition>Goldmann-Favre Syndrome</condition>
  <condition>Gyrate Atrophy</condition>
  <condition>Juvenile Macular Degeneration</condition>
  <condition>Kearns-Sayre Syndrome</condition>
  <condition>Leber Congenital Amaurosis</condition>
  <condition>Refsum Syndrome</condition>
  <condition>Retinitis Pigmentosa</condition>
  <condition>Retinitis Punctata Albescens</condition>
  <condition>Retinoschisis</condition>
  <condition>Rod-Cone Dystrophy</condition>
  <condition>Rod Dystrophy</condition>
  <condition>Rod Monochromacy</condition>
  <condition>Stargardt Disease</condition>
  <condition>Usher Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Affected individuals, all ages including minors registered by their parent or guardian.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with an inherited retinal degenerative disease OR&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glaucoma only&#xD;
&#xD;
          -  Diabetic retinopathy only&#xD;
&#xD;
          -  Non-retinal disease&#xD;
&#xD;
          -  Not heritable retinal disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd Durham, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vice President, Clinical and Outcomes Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Registry Coordinator</last_name>
    <phone>800-683-5555</phone>
    <phone_ext>1594</phone_ext>
    <email>Coordinator@MyRetinaTracker.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Foundation Fighting Blindness</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Registry Coordinator</last_name>
      <phone>800-683-5555</phone>
      <phone_ext>1594</phone_ext>
      <email>Coordinator@MyRetinaTracker.org</email>
    </contact>
    <investigator>
      <last_name>Todd Durham, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.myretinatracker.org/</url>
    <description>On-line registration site for registry participants, clinicians and researchers</description>
  </link>
  <link>
    <url>https://www.fightingblindness.org</url>
    <description>Sponsor site offers general information about rare inherited retinal degenerative diseases studied by the Foundation.</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 3, 2015</study_first_submitted>
  <study_first_submitted_qc>May 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2015</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inherited retinal degenerative disease</keyword>
  <keyword>retinitis pigmentosa</keyword>
  <keyword>Usher</keyword>
  <keyword>Leber</keyword>
  <keyword>Bardet-Biedl</keyword>
  <keyword>Batten</keyword>
  <keyword>Best</keyword>
  <keyword>cone dystrophy</keyword>
  <keyword>cone-rod dystrophy</keyword>
  <keyword>choroideremia</keyword>
  <keyword>congenital night blindness</keyword>
  <keyword>enhanced s-cone</keyword>
  <keyword>cone monochromacy</keyword>
  <keyword>Goldmann-Favre</keyword>
  <keyword>Kearns-Sayre</keyword>
  <keyword>Refsum</keyword>
  <keyword>retinoschisis</keyword>
  <keyword>rod-cone dystrophy</keyword>
  <keyword>rod dystrophy</keyword>
  <keyword>rod monochromacy</keyword>
  <keyword>Sorsby pseudoinflammatory dystrophy</keyword>
  <keyword>stargardt</keyword>
  <keyword>achromatopsia</keyword>
  <keyword>juvenile inherited macular degeneration</keyword>
  <keyword>cone dichromacy</keyword>
  <keyword>cone trichromacy</keyword>
  <keyword>Charcot-Marie-Tooth</keyword>
  <keyword>albipunctate dystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kearns-Sayre Syndrome</mesh_term>
    <mesh_term>Usher Syndromes</mesh_term>
    <mesh_term>Blindness</mesh_term>
    <mesh_term>Neuronal Ceroid-Lipofuscinoses</mesh_term>
    <mesh_term>Color Vision Defects</mesh_term>
    <mesh_term>Bardet-Biedl Syndrome</mesh_term>
    <mesh_term>Laurence-Moon Syndrome</mesh_term>
    <mesh_term>Refsum Disease</mesh_term>
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Leber Congenital Amaurosis</mesh_term>
    <mesh_term>Stargardt Disease</mesh_term>
    <mesh_term>Choroideremia</mesh_term>
    <mesh_term>Retinoschisis</mesh_term>
    <mesh_term>Cone Dystrophy</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
    <mesh_term>Gyrate Atrophy</mesh_term>
    <mesh_term>Eye Diseases, Hereditary</mesh_term>
    <mesh_term>Abetalipoproteinemia</mesh_term>
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

